Results 1 to 10 of about 336,993 (238)

Reprogramming Cancer Cells to Antigen-presenting Cells [PDF]

open access: yesBio-Protocol, 2023
Cancer cells evade the immune system by downregulating antigen presentation. Although immune checkpoint inhibitors (ICI) and adoptive T-cell therapies revolutionized cancer treatment, their efficacy relies on the intrinsic immunogenicity of tumor cells ...
Alexandra Ferreira   +5 more
doaj   +2 more sources

Antigen-Presenting Cells in Psoriasis [PDF]

open access: yesLife, 2022
Psoriasis is classically considered a chronic inflammatory skin disorder, however the identification of autoantigens in its pathogenesis established it as a T cell mediated autoimmune disease.
Dóra Antal   +4 more
doaj   +3 more sources

Antigenic peptide delivery to antigen-presenting cells using a CD40-coiled coil affinity-based platform [PDF]

open access: yesDrug Delivery
Delivery of antigenic peptides to antigen presenting cells (APCs) such as dendritic cells (DCs) using monoclonal antibodies (mAbs) is an attractive approach to evoke antigen-specific T cell activation and improve drug efficacy.
Barnabas Nyesiga   +6 more
doaj   +2 more sources

Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells [PDF]

open access: yesCell Journal, 2023
Objective: Chimeric antigen receptor (CAR) T cell therapy has recently emerged as a promising approach for thetreatment of different types of cancer.
Ali Sayadmanesh   +7 more
doaj   +1 more source

CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation

open access: yesFrontiers in Immunology, 2021
Autoimmune uveitis is a sight-threatening ocular inflammatory condition in which the retina and uveal tissues become a target of autoreactive immune cells.
Yoko Okunuki   +3 more
doaj   +1 more source

Comprehensive single-cell analysis reveals novel anergic antigen-presenting cell subtypes in human sepsis

open access: yesFrontiers in Immunology, 2023
BackgroundSepsis is a life-threatening condition with high mortality. A few studies have emerged utilizing single-cell RNA sequencing (scRNA-seq) to analyze gene expression at the single-cell resolution in sepsis, but a comprehensive high-resolution ...
Tuo Zhang   +17 more
doaj   +1 more source

Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer

open access: yesCells, 2022
Dendritic cells (DCs) are a unique myeloid cell lineage that play a central role in the priming of the adaptive immune response. As such, they are an attractive target for immune oncology based therapeutic approaches.
Enrica Marmonti   +2 more
doaj   +1 more source

Daratumumab prevents programmed death ligand‐1 expression on antigen‐presenting cells in de novo multiple myeloma

open access: yesCancer Medicine, 2020
Background Daratumumab (Dara), an anti‐CD38 monoclonal antibody, has an immunologic mechanism of action through targeting of CD38 expressing immune cells in patients with multiple myeloma (MM). Furthermore, it was recently shown that CD38 upregulation in
Nicolas Stocker   +6 more
doaj   +1 more source

Increased genital mucosal cytokines in Canadian women associate with higher antigen-presenting cells, inflammatory metabolites, epithelial barrier disruption, and the depletion of L. crispatus

open access: yesMicrobiome, 2023
Background Cervicovaginal inflammation has been linked to negative reproductive health outcomes including the acquisition of HIV, other sexually transmitted infections, and cervical carcinogenesis. While changes to the vaginal microbiome have been linked
Christina Farr Zuend   +20 more
doaj   +1 more source

Recent Advances in Experimental Dendritic Cell Vaccines for Cancer

open access: yesFrontiers in Oncology, 2021
The development of immunotherapeutic methods for the treatment of oncological diseases have made it possible to improve the effectiveness of standard therapies.
Ivan Y. Filin   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy